# A Dose-Escalation Study of RO7875913 in Healthy Participants

> **NCT07342114** · PHASE1 · RECRUITING · sponsor: **Genentech, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** RO7875913
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07342114
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-11
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07342114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07342114, "A Dose-Escalation Study of RO7875913 in Healthy Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07342114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*